Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Pip Care provides a personalized surgical journey platform, optimizing perioperative care processes and supporting patients and care teams.
Self-Driven Neurological Assessments
Resvita Bio develops and manufactures engineered probiotics for use in treatment if skin related diseases including cancer.
Lasarrus develops devices for patients with chronic obstructive pulmonary disease.
Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.
EndoTheia is a medical equipment manufacturing firm that supplies the next generation of flexible endoscopic devices.
Medical Device Research and Development
Xylyx Bio creates effective science-based solutions for the benefit of human life and health.
ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.
Inflammatix develops rapid immune system diagnostics to improve patient care and public health.
CoapTech is an early-stage medical device company aiming to improve medical care delivery for patients young and old around the world.
Remote Therapeutic Monitoring for Mental Health Treatments
Evoq Therapeutics is a cancer immunotherapy company that provides disease-specific immune modulators.
Reduce clinical variation and gain 10x efficiencies – continuous insights and monitoring
This company is a Boston-based biopharmaceutical company developing immune-based approaches.
Penderia Technologies is a new medical device company that specializes in creative ways to treat orthopedic ailments.
Aldatu Biosciences is the leader in adaptive PCR diagnostics for global health and emerging diseases.
MaMome uses microbiome analysis and ML to improve maternal health by detecting high-risk pregnancies early.
Orlance provides more effective therapeutic and preventive vaccines for a wide spectrum of viral targets.
Magnetic Insight is a biotechnology company that offers cellular imaging to measure the efficacy of cancer immunotherapies.
Metaclipse Therapeutics Corporation is a preclinical-stage biotechnology company
CUNY SPH delivers online graduate education that prepares students for success in all domains of public health.
Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases.
Raydiant Oximetry is a medical device company focused on improving outcomes for mothers and babies during childbirth.
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Health Care, Biotechnology, Medical, Therapeutics, Medical Device. The firm invests across 25 different industry categories.
Among tracked funding rounds, ONL Therapeutics received $65.0M in a Series D round. National Institutes of Health's total known invested capital is $2.7B.
National Institutes of Health's average investment size is $5.4M across its portfolio of 491 companies.
Recent National Institutes of Health portfolio additions include Pip Care, Modality.AI, Inc., Resvita Bio, Lasarrus, Dignify Therapeutics. These companies were founded in 2020 or later.